scholarly journals Comparison Between SMILES-Based Differential Neural Computer and Recurrent Neural Network Architectures for De Novo Molecule Design

2019 ◽  
Author(s):  
Simon Johansson ◽  
Oleksii Ptykhodko ◽  
Josep Arús-Pous ◽  
Ola Engkvist ◽  
Hongming Chen

In recent years, deep learning for de novo molecular generation has become a rapidly growing research area. Recurrent neural networks (RNN) using the SMILES molecular representation is one of the most common approaches used. Recent study shows that the differentiable neural computer (DNC) can make considerable improvement over the RNN for modeling of sequential data. In the current study, DNC has been implemented as an extension to REINVENT, an RNN-based model that has already been used successfully to make de novo molecular design. The model was benchmarked on its capacity to learn the SMILES language on the GDB-13 and MOSES datasets. The DNC shows improvement on all test cases conducted at the cost of significantly increased computational time and memory consumption.

Author(s):  
Simon Johansson ◽  
Oleksii Ptykhodko ◽  
Josep Arús-Pous ◽  
Ola Engkvist ◽  
Hongming Chen

In recent years, deep learning for de novo molecular generation has become a rapidly growing research area. Recurrent neural networks (RNN) using the SMILES molecular representation is one of the most common approaches used. Recent study shows that the differentiable neural computer (DNC) can make considerable improvement over the RNN for modeling of sequential data. In the current study, DNC has been implemented as an extension to REINVENT, an RNN-based model that has already been used successfully to make de novo molecular design. The model was benchmarked on its capacity to learn the SMILES language on the GDB-13 and MOSES datasets. The DNC shows improvement on all test cases conducted at the cost of significantly increased computational time and memory consumption.


2021 ◽  
Author(s):  
Orion Dollar ◽  
Nisarg Joshi ◽  
David Beck ◽  
Jim Pfaendtner

Attention mechanisms have led to many breakthroughs in sequential data modeling but have yet to be incorporated into any generative algorithms for molecular design. Here we explore the impact of...


Author(s):  
Joshua Meyers ◽  
Benedek Fabian ◽  
Nathan Brown

1994 ◽  
Vol 37 (23) ◽  
pp. 3994-4002 ◽  
Author(s):  
Bohdan Waszkowycz ◽  
David E. Clark ◽  
David Frenkel ◽  
Jin Li ◽  
Christopher W. Murray ◽  
...  

1995 ◽  
Vol 9 (1) ◽  
pp. 13-32 ◽  
Author(s):  
David E. Clark ◽  
David Frenkel ◽  
Stephen A. Levy ◽  
Jin Li ◽  
Christopher W. Murray ◽  
...  

2019 ◽  
Vol 59 (3) ◽  
pp. 1182-1196 ◽  
Author(s):  
Boris Sattarov ◽  
Igor I. Baskin ◽  
Dragos Horvath ◽  
Gilles Marcou ◽  
Esben Jannik Bjerrum ◽  
...  

2020 ◽  
Author(s):  
Thomas Blaschke ◽  
Ola Engkvist ◽  
Jürgen Bajorath ◽  
Hongming Chen

Abstract In de novo molecular design, recurrent neural networks (RNN) have been shown to be effective methods for sampling and generating novel chemical structures. Using a technique called reinforcement learning (RL), an RNN can be tuned to target a particular section of chemical space with optimized desirable properties using a scoring function. However, ligands generated by current RL methods so far tend to have relatively low diversity, and sometimes even result in duplicate structures when optimizing towards desired properties. Here, we propose a new method to address the low diversity issue in RL for molecular design. Memory-assisted RL is an extension of the known RL, with the introduction of a so-called memory unit. As proof of concept, we applied our method to generate structures with a desired AlogP value. In a second case study, we applied our method to design ligands for the dopamine type 2 receptor and the 5-hydroxytryptamine type 1A receptor. For both receptors, a machine learning model was developed to predict whether generated molecules were active or not for the receptor. In both case studies, it was found that memory-assisted RL led to the generation of more compounds predicted to be active having higher chemical diversity, thus achieving better coverage of chemical space of known ligands compared to established RL methods.


Author(s):  
Oleksii Prykhodko ◽  
Simon Viet Johansson ◽  
Panagiotis-Christos Kotsias ◽  
Josep Arús-Pous ◽  
Esben Jannik Bjerrum ◽  
...  

<p> </p><p>Deep learning methods applied to drug discovery have been used to generate novel structures. In this study, we propose a new deep learning architecture, LatentGAN, which combines an autoencoder and a generative adversarial neural network for de novo molecular design. We applied the method in two scenarios: one to generate random drug-like compounds and another to generate target-biased compounds. Our results show that the method works well in both cases: sampled compounds from the trained model can largely occupy the same chemical space as the training set and also generate a substantial fraction of novel compounds. Moreover, the drug-likeness score of compounds sampled from LatentGAN is also similar to that of the training set. Lastly, generated compounds differ from those obtained with a Recurrent Neural Network-based generative model approach, indicating that both methods can be used complementarily.</p><p> </p>


Sign in / Sign up

Export Citation Format

Share Document